Global Central Nervous System (CNS) Drug Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Central Nervous System (CNS) Drug market size was valued at US$ 113720 million in 2023. With growing demand in downstream market, the Central Nervous System (CNS) Drug is forecast to a readjusted size of US$ 185760 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Central Nervous System (CNS) Drug market. Central Nervous System (CNS) Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Central Nervous System (CNS) Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Central Nervous System (CNS) Drug market.
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
The presence of strong pipeline products is expected to drive the central nervous system therapeutics market over the forecast period. Major pharmaceutical companies are focusing on new treatments to prevent or improve symptoms of neurological diseases.
Key Features:
The report on Central Nervous System (CNS) Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Central Nervous System (CNS) Drug market. It may include historical data, market segmentation by Type (e.g., Prescription Drugs, OTC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Central Nervous System (CNS) Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Central Nervous System (CNS) Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Central Nervous System (CNS) Drug industry. This include advancements in Central Nervous System (CNS) Drug technology, Central Nervous System (CNS) Drug new entrants, Central Nervous System (CNS) Drug new investment, and other innovations that are shaping the future of Central Nervous System (CNS) Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Central Nervous System (CNS) Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Central Nervous System (CNS) Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Central Nervous System (CNS) Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Central Nervous System (CNS) Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Central Nervous System (CNS) Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Central Nervous System (CNS) Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Central Nervous System (CNS) Drug market.
Market Segmentation:
Central Nervous System (CNS) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Central Nervous System (CNS) Drug market size was valued at US$ 113720 million in 2023. With growing demand in downstream market, the Central Nervous System (CNS) Drug is forecast to a readjusted size of US$ 185760 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Central Nervous System (CNS) Drug market. Central Nervous System (CNS) Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Central Nervous System (CNS) Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Central Nervous System (CNS) Drug market.
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
The presence of strong pipeline products is expected to drive the central nervous system therapeutics market over the forecast period. Major pharmaceutical companies are focusing on new treatments to prevent or improve symptoms of neurological diseases.
Key Features:
The report on Central Nervous System (CNS) Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Central Nervous System (CNS) Drug market. It may include historical data, market segmentation by Type (e.g., Prescription Drugs, OTC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Central Nervous System (CNS) Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Central Nervous System (CNS) Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Central Nervous System (CNS) Drug industry. This include advancements in Central Nervous System (CNS) Drug technology, Central Nervous System (CNS) Drug new entrants, Central Nervous System (CNS) Drug new investment, and other innovations that are shaping the future of Central Nervous System (CNS) Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Central Nervous System (CNS) Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Central Nervous System (CNS) Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Central Nervous System (CNS) Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Central Nervous System (CNS) Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Central Nervous System (CNS) Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Central Nervous System (CNS) Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Central Nervous System (CNS) Drug market.
Market Segmentation:
Central Nervous System (CNS) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Prescription Drugs
- OTC
- MS Therapeutics
- Antipsychotic Drugs
- Depression Drugs
- Epilepsy Drugs
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Pfizer Inc
- Novartis AG
- GSK
- Eli Lilly
- Teva
- Otsuka Pharmaceutical Co., Ltd
- Biogen Inc
- Boehringer Ingelheim
- Roche
- UCB
- Tekeda
- Shanghai Fosun
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System (CNS) Drug Market Size 2019-2030
2.1.2 Central Nervous System (CNS) Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Central Nervous System (CNS) Drug Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC
2.3 Central Nervous System (CNS) Drug Market Size by Type
2.3.1 Central Nervous System (CNS) Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
2.4 Central Nervous System (CNS) Drug Segment by Application
2.4.1 MS Therapeutics
2.4.2 Antipsychotic Drugs
2.4.3 Depression Drugs
2.4.4 Epilepsy Drugs
2.4.5 Others
2.5 Central Nervous System (CNS) Drug Market Size by Application
2.5.1 Central Nervous System (CNS) Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
3 CENTRAL NERVOUS SYSTEM (CNS) DRUG MARKET SIZE BY PLAYER
3.1 Central Nervous System (CNS) Drug Market Size Market Share by Players
3.1.1 Global Central Nervous System (CNS) Drug Revenue by Players (2019-2024)
3.1.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2019-2024)
3.2 Global Central Nervous System (CNS) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM (CNS) DRUG BY REGIONS
4.1 Central Nervous System (CNS) Drug Market Size by Regions (2019-2024)
4.2 Americas Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.3 APAC Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.4 Europe Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Central Nervous System (CNS) Drug Market Size by Country (2019-2024)
5.2 Americas Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
5.3 Americas Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System (CNS) Drug Market Size by Region (2019-2024)
6.2 APAC Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
6.3 APAC Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System (CNS) Drug by Country (2019-2024)
7.2 Europe Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
7.3 Europe Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System (CNS) Drug by Region (2019-2024)
8.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) DRUG MARKET FORECAST
10.1 Global Central Nervous System (CNS) Drug Forecast by Regions (2025-2030)
10.1.1 Global Central Nervous System (CNS) Drug Forecast by Regions (2025-2030)
10.1.2 Americas Central Nervous System (CNS) Drug Forecast
10.1.3 APAC Central Nervous System (CNS) Drug Forecast
10.1.4 Europe Central Nervous System (CNS) Drug Forecast
10.1.5 Middle East & Africa Central Nervous System (CNS) Drug Forecast
10.2 Americas Central Nervous System (CNS) Drug Forecast by Country (2025-2030)
10.2.1 United States Central Nervous System (CNS) Drug Market Forecast
10.2.2 Canada Central Nervous System (CNS) Drug Market Forecast
10.2.3 Mexico Central Nervous System (CNS) Drug Market Forecast
10.2.4 Brazil Central Nervous System (CNS) Drug Market Forecast
10.3 APAC Central Nervous System (CNS) Drug Forecast by Region (2025-2030)
10.3.1 China Central Nervous System (CNS) Drug Market Forecast
10.3.2 Japan Central Nervous System (CNS) Drug Market Forecast
10.3.3 Korea Central Nervous System (CNS) Drug Market Forecast
10.3.4 Southeast Asia Central Nervous System (CNS) Drug Market Forecast
10.3.5 India Central Nervous System (CNS) Drug Market Forecast
10.3.6 Australia Central Nervous System (CNS) Drug Market Forecast
10.4 Europe Central Nervous System (CNS) Drug Forecast by Country (2025-2030)
10.4.1 Germany Central Nervous System (CNS) Drug Market Forecast
10.4.2 France Central Nervous System (CNS) Drug Market Forecast
10.4.3 UK Central Nervous System (CNS) Drug Market Forecast
10.4.4 Italy Central Nervous System (CNS) Drug Market Forecast
10.4.5 Russia Central Nervous System (CNS) Drug Market Forecast
10.5 Middle East & Africa Central Nervous System (CNS) Drug Forecast by Region (2025-2030)
10.5.1 Egypt Central Nervous System (CNS) Drug Market Forecast
10.5.2 South Africa Central Nervous System (CNS) Drug Market Forecast
10.5.3 Israel Central Nervous System (CNS) Drug Market Forecast
10.5.4 Turkey Central Nervous System (CNS) Drug Market Forecast
10.5.5 GCC Countries Central Nervous System (CNS) Drug Market Forecast
10.6 Global Central Nervous System (CNS) Drug Forecast by Type (2025-2030)
10.7 Global Central Nervous System (CNS) Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Central Nervous System (CNS) Drug Product Offered
11.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Information
11.2.2 Pfizer Inc Central Nervous System (CNS) Drug Product Offered
11.2.3 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc Main Business Overview
11.2.5 Pfizer Inc Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Central Nervous System (CNS) Drug Product Offered
11.3.3 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Central Nervous System (CNS) Drug Product Offered
11.4.3 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GSK Main Business Overview
11.4.5 GSK Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Central Nervous System (CNS) Drug Product Offered
11.5.3 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Central Nervous System (CNS) Drug Product Offered
11.6.3 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Otsuka Pharmaceutical Co., Ltd
11.7.1 Otsuka Pharmaceutical Co., Ltd Company Information
11.7.2 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Offered
11.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Otsuka Pharmaceutical Co., Ltd Main Business Overview
11.7.5 Otsuka Pharmaceutical Co., Ltd Latest Developments
11.8 Biogen Inc
11.8.1 Biogen Inc Company Information
11.8.2 Biogen Inc Central Nervous System (CNS) Drug Product Offered
11.8.3 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Biogen Inc Main Business Overview
11.8.5 Biogen Inc Latest Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Central Nervous System (CNS) Drug Product Offered
11.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Boehringer Ingelheim Main Business Overview
11.9.5 Boehringer Ingelheim Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Central Nervous System (CNS) Drug Product Offered
11.10.3 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 UCB
11.11.1 UCB Company Information
11.11.2 UCB Central Nervous System (CNS) Drug Product Offered
11.11.3 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Tekeda
11.12.1 Tekeda Company Information
11.12.2 Tekeda Central Nervous System (CNS) Drug Product Offered
11.12.3 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Tekeda Main Business Overview
11.12.5 Tekeda Latest Developments
11.13 Shanghai Fosun
11.13.1 Shanghai Fosun Company Information
11.13.2 Shanghai Fosun Central Nervous System (CNS) Drug Product Offered
11.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shanghai Fosun Main Business Overview
11.13.5 Shanghai Fosun Latest Developments
11.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information
11.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Offered
11.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business Overview
11.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System (CNS) Drug Market Size 2019-2030
2.1.2 Central Nervous System (CNS) Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Central Nervous System (CNS) Drug Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC
2.3 Central Nervous System (CNS) Drug Market Size by Type
2.3.1 Central Nervous System (CNS) Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
2.4 Central Nervous System (CNS) Drug Segment by Application
2.4.1 MS Therapeutics
2.4.2 Antipsychotic Drugs
2.4.3 Depression Drugs
2.4.4 Epilepsy Drugs
2.4.5 Others
2.5 Central Nervous System (CNS) Drug Market Size by Application
2.5.1 Central Nervous System (CNS) Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
3 CENTRAL NERVOUS SYSTEM (CNS) DRUG MARKET SIZE BY PLAYER
3.1 Central Nervous System (CNS) Drug Market Size Market Share by Players
3.1.1 Global Central Nervous System (CNS) Drug Revenue by Players (2019-2024)
3.1.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2019-2024)
3.2 Global Central Nervous System (CNS) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM (CNS) DRUG BY REGIONS
4.1 Central Nervous System (CNS) Drug Market Size by Regions (2019-2024)
4.2 Americas Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.3 APAC Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.4 Europe Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Central Nervous System (CNS) Drug Market Size by Country (2019-2024)
5.2 Americas Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
5.3 Americas Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System (CNS) Drug Market Size by Region (2019-2024)
6.2 APAC Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
6.3 APAC Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System (CNS) Drug by Country (2019-2024)
7.2 Europe Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
7.3 Europe Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System (CNS) Drug by Region (2019-2024)
8.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) DRUG MARKET FORECAST
10.1 Global Central Nervous System (CNS) Drug Forecast by Regions (2025-2030)
10.1.1 Global Central Nervous System (CNS) Drug Forecast by Regions (2025-2030)
10.1.2 Americas Central Nervous System (CNS) Drug Forecast
10.1.3 APAC Central Nervous System (CNS) Drug Forecast
10.1.4 Europe Central Nervous System (CNS) Drug Forecast
10.1.5 Middle East & Africa Central Nervous System (CNS) Drug Forecast
10.2 Americas Central Nervous System (CNS) Drug Forecast by Country (2025-2030)
10.2.1 United States Central Nervous System (CNS) Drug Market Forecast
10.2.2 Canada Central Nervous System (CNS) Drug Market Forecast
10.2.3 Mexico Central Nervous System (CNS) Drug Market Forecast
10.2.4 Brazil Central Nervous System (CNS) Drug Market Forecast
10.3 APAC Central Nervous System (CNS) Drug Forecast by Region (2025-2030)
10.3.1 China Central Nervous System (CNS) Drug Market Forecast
10.3.2 Japan Central Nervous System (CNS) Drug Market Forecast
10.3.3 Korea Central Nervous System (CNS) Drug Market Forecast
10.3.4 Southeast Asia Central Nervous System (CNS) Drug Market Forecast
10.3.5 India Central Nervous System (CNS) Drug Market Forecast
10.3.6 Australia Central Nervous System (CNS) Drug Market Forecast
10.4 Europe Central Nervous System (CNS) Drug Forecast by Country (2025-2030)
10.4.1 Germany Central Nervous System (CNS) Drug Market Forecast
10.4.2 France Central Nervous System (CNS) Drug Market Forecast
10.4.3 UK Central Nervous System (CNS) Drug Market Forecast
10.4.4 Italy Central Nervous System (CNS) Drug Market Forecast
10.4.5 Russia Central Nervous System (CNS) Drug Market Forecast
10.5 Middle East & Africa Central Nervous System (CNS) Drug Forecast by Region (2025-2030)
10.5.1 Egypt Central Nervous System (CNS) Drug Market Forecast
10.5.2 South Africa Central Nervous System (CNS) Drug Market Forecast
10.5.3 Israel Central Nervous System (CNS) Drug Market Forecast
10.5.4 Turkey Central Nervous System (CNS) Drug Market Forecast
10.5.5 GCC Countries Central Nervous System (CNS) Drug Market Forecast
10.6 Global Central Nervous System (CNS) Drug Forecast by Type (2025-2030)
10.7 Global Central Nervous System (CNS) Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Central Nervous System (CNS) Drug Product Offered
11.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Information
11.2.2 Pfizer Inc Central Nervous System (CNS) Drug Product Offered
11.2.3 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc Main Business Overview
11.2.5 Pfizer Inc Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Central Nervous System (CNS) Drug Product Offered
11.3.3 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Central Nervous System (CNS) Drug Product Offered
11.4.3 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GSK Main Business Overview
11.4.5 GSK Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Central Nervous System (CNS) Drug Product Offered
11.5.3 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Central Nervous System (CNS) Drug Product Offered
11.6.3 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Otsuka Pharmaceutical Co., Ltd
11.7.1 Otsuka Pharmaceutical Co., Ltd Company Information
11.7.2 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Offered
11.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Otsuka Pharmaceutical Co., Ltd Main Business Overview
11.7.5 Otsuka Pharmaceutical Co., Ltd Latest Developments
11.8 Biogen Inc
11.8.1 Biogen Inc Company Information
11.8.2 Biogen Inc Central Nervous System (CNS) Drug Product Offered
11.8.3 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Biogen Inc Main Business Overview
11.8.5 Biogen Inc Latest Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Central Nervous System (CNS) Drug Product Offered
11.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Boehringer Ingelheim Main Business Overview
11.9.5 Boehringer Ingelheim Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Central Nervous System (CNS) Drug Product Offered
11.10.3 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 UCB
11.11.1 UCB Company Information
11.11.2 UCB Central Nervous System (CNS) Drug Product Offered
11.11.3 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Tekeda
11.12.1 Tekeda Company Information
11.12.2 Tekeda Central Nervous System (CNS) Drug Product Offered
11.12.3 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Tekeda Main Business Overview
11.12.5 Tekeda Latest Developments
11.13 Shanghai Fosun
11.13.1 Shanghai Fosun Company Information
11.13.2 Shanghai Fosun Central Nervous System (CNS) Drug Product Offered
11.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shanghai Fosun Main Business Overview
11.13.5 Shanghai Fosun Latest Developments
11.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information
11.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Offered
11.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business Overview
11.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Central Nervous System (CNS) Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Prescription Drugs
Table 3. Major Players of OTC
Table 4. Central Nervous System (CNS) Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 7. Central Nervous System (CNS) Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 10. Global Central Nervous System (CNS) Drug Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Central Nervous System (CNS) Drug Revenue Market Share by Player (2019-2024)
Table 12. Central Nervous System (CNS) Drug Key Players Head office and Products Offered
Table 13. Central Nervous System (CNS) Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Central Nervous System (CNS) Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Central Nervous System (CNS) Drug Market Size Market Share by Regions (2019-2024)
Table 18. Global Central Nervous System (CNS) Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Central Nervous System (CNS) Drug Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Central Nervous System (CNS) Drug Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Central Nervous System (CNS) Drug Market Size Market Share by Country (2019-2024)
Table 22. Americas Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 24. Americas Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 26. APAC Central Nervous System (CNS) Drug Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Table 28. APAC Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 30. APAC Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 32. Europe Central Nervous System (CNS) Drug Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Central Nervous System (CNS) Drug Market Size Market Share by Country (2019-2024)
Table 34. Europe Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 36. Europe Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Central Nervous System (CNS) Drug
Table 45. Key Market Challenges & Risks of Central Nervous System (CNS) Drug
Table 46. Key Industry Trends of Central Nervous System (CNS) Drug
Table 47. Global Central Nervous System (CNS) Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Central Nervous System (CNS) Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Central Nervous System (CNS) Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Johnson & Johnson Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 52. Johnson & Johnson Central Nervous System (CNS) Drug Product Offered
Table 53. Johnson & Johnson Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. Pfizer Inc Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 57. Pfizer Inc Central Nervous System (CNS) Drug Product Offered
Table 58. Pfizer Inc Main Business
Table 59. Pfizer Inc Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Inc Latest Developments
Table 61. Novartis AG Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 62. Novartis AG Central Nervous System (CNS) Drug Product Offered
Table 63. Novartis AG Main Business
Table 64. Novartis AG Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis AG Latest Developments
Table 66. GSK Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 67. GSK Central Nervous System (CNS) Drug Product Offered
Table 68. GSK Main Business
Table 69. GSK Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. GSK Latest Developments
Table 71. Eli Lilly Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 72. Eli Lilly Central Nervous System (CNS) Drug Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Eli Lilly Latest Developments
Table 76. Teva Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 77. Teva Central Nervous System (CNS) Drug Product Offered
Table 78. Teva Main Business
Table 79. Teva Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Teva Latest Developments
Table 81. Otsuka Pharmaceutical Co., Ltd Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 82. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Offered
Table 83. Otsuka Pharmaceutical Co., Ltd Main Business
Table 84. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Otsuka Pharmaceutical Co., Ltd Latest Developments
Table 86. Biogen Inc Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 87. Biogen Inc Central Nervous System (CNS) Drug Product Offered
Table 88. Biogen Inc Main Business
Table 89. Biogen Inc Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Biogen Inc Latest Developments
Table 91. Boehringer Ingelheim Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 92. Boehringer Ingelheim Central Nervous System (CNS) Drug Product Offered
Table 93. Boehringer Ingelheim Main Business
Table 94. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Boehringer Ingelheim Latest Developments
Table 96. Roche Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 97. Roche Central Nervous System (CNS) Drug Product Offered
Table 98. Roche Main Business
Table 99. Roche Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Roche Latest Developments
Table 101. UCB Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 102. UCB Central Nervous System (CNS) Drug Product Offered
Table 103. UCB Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. UCB Main Business
Table 105. UCB Latest Developments
Table 106. Tekeda Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 107. Tekeda Central Nervous System (CNS) Drug Product Offered
Table 108. Tekeda Main Business
Table 109. Tekeda Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Tekeda Latest Developments
Table 111. Shanghai Fosun Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 112. Shanghai Fosun Central Nervous System (CNS) Drug Product Offered
Table 113. Shanghai Fosun Main Business
Table 114. Shanghai Fosun Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Shanghai Fosun Latest Developments
Table 116. Jiangsu Nhwa Pharmaceutical Co., Ltd. Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 117. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Offered
Table 118. Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business
Table 119. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Jiangsu Nhwa Pharmaceutical Co., Ltd. Latest Developments
Table 1. Central Nervous System (CNS) Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Prescription Drugs
Table 3. Major Players of OTC
Table 4. Central Nervous System (CNS) Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 7. Central Nervous System (CNS) Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 10. Global Central Nervous System (CNS) Drug Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Central Nervous System (CNS) Drug Revenue Market Share by Player (2019-2024)
Table 12. Central Nervous System (CNS) Drug Key Players Head office and Products Offered
Table 13. Central Nervous System (CNS) Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Central Nervous System (CNS) Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Central Nervous System (CNS) Drug Market Size Market Share by Regions (2019-2024)
Table 18. Global Central Nervous System (CNS) Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Central Nervous System (CNS) Drug Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Central Nervous System (CNS) Drug Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Central Nervous System (CNS) Drug Market Size Market Share by Country (2019-2024)
Table 22. Americas Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 24. Americas Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 26. APAC Central Nervous System (CNS) Drug Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Table 28. APAC Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 30. APAC Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 32. Europe Central Nervous System (CNS) Drug Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Central Nervous System (CNS) Drug Market Size Market Share by Country (2019-2024)
Table 34. Europe Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 36. Europe Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Central Nervous System (CNS) Drug
Table 45. Key Market Challenges & Risks of Central Nervous System (CNS) Drug
Table 46. Key Industry Trends of Central Nervous System (CNS) Drug
Table 47. Global Central Nervous System (CNS) Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Central Nervous System (CNS) Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Central Nervous System (CNS) Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Johnson & Johnson Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 52. Johnson & Johnson Central Nervous System (CNS) Drug Product Offered
Table 53. Johnson & Johnson Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. Pfizer Inc Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 57. Pfizer Inc Central Nervous System (CNS) Drug Product Offered
Table 58. Pfizer Inc Main Business
Table 59. Pfizer Inc Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Inc Latest Developments
Table 61. Novartis AG Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 62. Novartis AG Central Nervous System (CNS) Drug Product Offered
Table 63. Novartis AG Main Business
Table 64. Novartis AG Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis AG Latest Developments
Table 66. GSK Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 67. GSK Central Nervous System (CNS) Drug Product Offered
Table 68. GSK Main Business
Table 69. GSK Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. GSK Latest Developments
Table 71. Eli Lilly Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 72. Eli Lilly Central Nervous System (CNS) Drug Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Eli Lilly Latest Developments
Table 76. Teva Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 77. Teva Central Nervous System (CNS) Drug Product Offered
Table 78. Teva Main Business
Table 79. Teva Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Teva Latest Developments
Table 81. Otsuka Pharmaceutical Co., Ltd Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 82. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Offered
Table 83. Otsuka Pharmaceutical Co., Ltd Main Business
Table 84. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Otsuka Pharmaceutical Co., Ltd Latest Developments
Table 86. Biogen Inc Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 87. Biogen Inc Central Nervous System (CNS) Drug Product Offered
Table 88. Biogen Inc Main Business
Table 89. Biogen Inc Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Biogen Inc Latest Developments
Table 91. Boehringer Ingelheim Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 92. Boehringer Ingelheim Central Nervous System (CNS) Drug Product Offered
Table 93. Boehringer Ingelheim Main Business
Table 94. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Boehringer Ingelheim Latest Developments
Table 96. Roche Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 97. Roche Central Nervous System (CNS) Drug Product Offered
Table 98. Roche Main Business
Table 99. Roche Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Roche Latest Developments
Table 101. UCB Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 102. UCB Central Nervous System (CNS) Drug Product Offered
Table 103. UCB Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. UCB Main Business
Table 105. UCB Latest Developments
Table 106. Tekeda Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 107. Tekeda Central Nervous System (CNS) Drug Product Offered
Table 108. Tekeda Main Business
Table 109. Tekeda Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Tekeda Latest Developments
Table 111. Shanghai Fosun Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 112. Shanghai Fosun Central Nervous System (CNS) Drug Product Offered
Table 113. Shanghai Fosun Main Business
Table 114. Shanghai Fosun Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Shanghai Fosun Latest Developments
Table 116. Jiangsu Nhwa Pharmaceutical Co., Ltd. Details, Company Type, Central Nervous System (CNS) Drug Area Served and Its Competitors
Table 117. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Offered
Table 118. Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business
Table 119. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Jiangsu Nhwa Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Central Nervous System (CNS) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System (CNS) Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Central Nervous System (CNS) Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Central Nervous System (CNS) Drug Sales Market Share by Country/Region (2023)
Figure 8. Central Nervous System (CNS) Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Central Nervous System (CNS) Drug Market Size Market Share by Type in 2023
Figure 10. Central Nervous System (CNS) Drug in MS Therapeutics
Figure 11. Global Central Nervous System (CNS) Drug Market: MS Therapeutics (2019-2024) & ($ Millions)
Figure 12. Central Nervous System (CNS) Drug in Antipsychotic Drugs
Figure 13. Global Central Nervous System (CNS) Drug Market: Antipsychotic Drugs (2019-2024) & ($ Millions)
Figure 14. Central Nervous System (CNS) Drug in Depression Drugs
Figure 15. Global Central Nervous System (CNS) Drug Market: Depression Drugs (2019-2024) & ($ Millions)
Figure 16. Central Nervous System (CNS) Drug in Epilepsy Drugs
Figure 17. Global Central Nervous System (CNS) Drug Market: Epilepsy Drugs (2019-2024) & ($ Millions)
Figure 18. Central Nervous System (CNS) Drug in Others
Figure 19. Global Central Nervous System (CNS) Drug Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Central Nervous System (CNS) Drug Market Size Market Share by Application in 2023
Figure 21. Global Central Nervous System (CNS) Drug Revenue Market Share by Player in 2023
Figure 22. Global Central Nervous System (CNS) Drug Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 24. APAC Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 25. Europe Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 27. Americas Central Nervous System (CNS) Drug Value Market Share by Country in 2023
Figure 28. United States Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Central Nervous System (CNS) Drug Market Size Market Share by Region in 2023
Figure 33. APAC Central Nervous System (CNS) Drug Market Size Market Share by Type in 2023
Figure 34. APAC Central Nervous System (CNS) Drug Market Size Market Share by Application in 2023
Figure 35. China Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Central Nervous System (CNS) Drug Market Size Market Share by Country in 2023
Figure 42. Europe Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Figure 43. Europe Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Figure 44. Germany Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 58. APAC Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 59. Europe Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 61. United States Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 62. Canada Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 65. China Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 66. Japan Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 67. Korea Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 69. India Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 70. Australia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 71. Germany Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 72. France Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 73. UK Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 74. Italy Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 75. Russia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 76. Spain Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 79. Israel Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 82. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Central Nervous System (CNS) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System (CNS) Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Central Nervous System (CNS) Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Central Nervous System (CNS) Drug Sales Market Share by Country/Region (2023)
Figure 8. Central Nervous System (CNS) Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Central Nervous System (CNS) Drug Market Size Market Share by Type in 2023
Figure 10. Central Nervous System (CNS) Drug in MS Therapeutics
Figure 11. Global Central Nervous System (CNS) Drug Market: MS Therapeutics (2019-2024) & ($ Millions)
Figure 12. Central Nervous System (CNS) Drug in Antipsychotic Drugs
Figure 13. Global Central Nervous System (CNS) Drug Market: Antipsychotic Drugs (2019-2024) & ($ Millions)
Figure 14. Central Nervous System (CNS) Drug in Depression Drugs
Figure 15. Global Central Nervous System (CNS) Drug Market: Depression Drugs (2019-2024) & ($ Millions)
Figure 16. Central Nervous System (CNS) Drug in Epilepsy Drugs
Figure 17. Global Central Nervous System (CNS) Drug Market: Epilepsy Drugs (2019-2024) & ($ Millions)
Figure 18. Central Nervous System (CNS) Drug in Others
Figure 19. Global Central Nervous System (CNS) Drug Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Central Nervous System (CNS) Drug Market Size Market Share by Application in 2023
Figure 21. Global Central Nervous System (CNS) Drug Revenue Market Share by Player in 2023
Figure 22. Global Central Nervous System (CNS) Drug Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 24. APAC Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 25. Europe Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Central Nervous System (CNS) Drug Market Size 2019-2024 ($ Millions)
Figure 27. Americas Central Nervous System (CNS) Drug Value Market Share by Country in 2023
Figure 28. United States Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Central Nervous System (CNS) Drug Market Size Market Share by Region in 2023
Figure 33. APAC Central Nervous System (CNS) Drug Market Size Market Share by Type in 2023
Figure 34. APAC Central Nervous System (CNS) Drug Market Size Market Share by Application in 2023
Figure 35. China Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Central Nervous System (CNS) Drug Market Size Market Share by Country in 2023
Figure 42. Europe Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Figure 43. Europe Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Figure 44. Germany Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Central Nervous System (CNS) Drug Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Central Nervous System (CNS) Drug Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 58. APAC Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 59. Europe Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 61. United States Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 62. Canada Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 65. China Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 66. Japan Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 67. Korea Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 69. India Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 70. Australia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 71. Germany Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 72. France Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 73. UK Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 74. Italy Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 75. Russia Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 76. Spain Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 79. Israel Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Central Nervous System (CNS) Drug Market Size 2025-2030 ($ Millions)
Figure 82. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Central Nervous System (CNS) Drug Market Size Market Share Forecast by Application (2025-2030)
